Jin Ying, Fan Ying, Yan En-zhi, Liu Zhuo, Zong Zhi-hong, Qi Zhi-min
Department of Pharmacology, Jinzhou Medical College, Jinzhou 121001, China.
Acta Pharmacol Sin. 2006 Oct;27(10):1309-16. doi: 10.1111/j.1745-7254.2006.00414.x.
To observe the effects of sodium ferulate (SF) on amyloid beta (Abeta)1-40-induced p38 mitogen-activated protein kinase (MAPK) signal transduction pathway and the neuroprotective effects of SF.
Rats were injected intracerebroventricularly with Abeta1-40. Six hours after injection, Western blotting was used to determine the expressions of phosphorylated mitogen-activated protein kinase kinase (MKK) 3/MKK6, phospho-p38 MAPK, interleukin (IL)-1beta, phospho-MAPK activating protein kinase 2 (MAPKAPK-2), the 27 kDa heat shock protein (Hsp27), procaspase-9, -3, and -7 cleavage, and poly (ADP-ribose) polymerase (PARP) cleavage. Seven days after injection, Nissl staining was used to observe the morphological change in hippocampal CA1 regions.
Intracerebroventricular injection of Abeta1-40 induced an increase in phosphorylated MKK3/MKK6 and p38 MAPK expressions in hippocampal tissue. These increases, in combination with enhanced interleukin (IL)-1beta protein expression and reduced phospho-MAPKAPK2 and phospho-Hsp27 expression, mediate the Abeta-induced activation of cell death events as assessed by cleavage of procaspase-9, -3, and -7 and caspase-3 substrate PARP cleavage. Pretreatment with SF (100 mg/kg and 200 mg/kg daily, 3 weeks) significantly prevented Abeta1-40-induced increases in phosphorylated MKK3/MKK6 and p38 MAPK expression. The Abeta1-40-induced increase in IL-1beta protein level was attenuated by pretreatment with SF. In addition, Abeta1-40-induced decreases in phosphorylated MAPKAPK2 and Hsp27 expression were abrogated by administration of SF. In parallel with these findings, Abeta1-40-induced changes in activation of caspase-9, caspase-7, and caspase-3 were inhibited by pretreatment with SF.
SF prevents Abeta1-40-induced neurotoxicity through suppression of MKK3/MKK6-p38 MAPK activity and IL-1beta expression and upregulation of phospho-Hsp27 expression.
观察阿魏酸钠(SF)对β淀粉样蛋白(Aβ)1-40诱导的p38丝裂原活化蛋白激酶(MAPK)信号转导通路的影响以及SF的神经保护作用。
大鼠脑室内注射Aβ1-40。注射后6小时,采用蛋白质印迹法检测磷酸化丝裂原活化蛋白激酶激酶(MKK)3/MKK6、磷酸化p38 MAPK、白细胞介素(IL)-1β、磷酸化丝裂原活化蛋白激酶激活蛋白激酶2(MAPKAPK-2)、27 kDa热休克蛋白(Hsp27)、半胱天冬酶原-9、-3和-7的裂解以及聚(ADP-核糖)聚合酶(PARP)的裂解表达。注射后7天,采用尼氏染色观察海马CA1区的形态变化。
脑室内注射Aβ1-40可诱导海马组织中磷酸化MKK3/MKK6和p38 MAPK表达增加。这些增加,连同白细胞介素(IL)-1β蛋白表达增强以及磷酸化MAPKAPK2和磷酸化Hsp27表达降低,介导了Aβ诱导的细胞死亡事件激活,这通过半胱天冬酶原-9、-3和-7的裂解以及半胱天冬酶-3底物PARP的裂解来评估。用SF(每日100 mg/kg和200 mg/kg,3周)预处理可显著阻止Aβ1-40诱导的磷酸化MKK3/MKK6和p38 MAPK表达增加。用SF预处理可减弱Aβ1-40诱导的IL-1β蛋白水平升高。此外,给予SF可消除Aβ1-40诱导的磷酸化MAPKAPK2和Hsp27表达降低。与这些发现一致,用SF预处理可抑制Aβ1-40诱导的半胱天冬酶-9、半胱天冬酶-7和半胱天冬酶-3激活变化。
SF通过抑制MKK3/MKK6-p38 MAPK活性和IL-1β表达以及上调磷酸化Hsp27表达来预防Aβ1-40诱导的神经毒性。